QUANTUM GENOMICS SAS-REGR (ALQGC.PA) Stock Fundamental Analysis

EPA:ALQGC • FR0011648971

0.0721 EUR
0 (-1.77%)
Last: Oct 24, 2024, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership
Fundamental Rating

1

Overall ALQGC gets a fundamental rating of 1 out of 10. We evaluated ALQGC against 77 industry peers in the Biotechnology industry. Both the profitability and financial health of ALQGC have multiple concerns. ALQGC is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • ALQGC had negative earnings in the past year.
  • ALQGC had negative earnings in each of the past 5 years.
  • In the past 5 years ALQGC always reported negative operating cash flow.
ALQGC.PA Yearly Net Income VS EBIT VS OCF VS FCFALQGC.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 -10M -20M -30M

1.2 Ratios

  • The Return On Assets of ALQGC (-84.63%) is worse than 80.00% of its industry peers.
  • ALQGC's Return On Equity of -726.18% is on the low side compared to the rest of the industry. ALQGC is outperformed by 75.71% of its industry peers.
Industry RankSector Rank
ROA -84.63%
ROE -726.18%
ROIC N/A
ROA(3y)-87.78%
ROA(5y)-71.29%
ROE(3y)-517.57%
ROE(5y)-335.54%
ROIC(3y)N/A
ROIC(5y)N/A
ALQGC.PA Yearly ROA, ROE, ROICALQGC.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 -200 -400 -600

1.3 Margins

  • ALQGC does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ALQGC.PA Yearly Profit, Operating, Gross MarginsALQGC.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 -10K -20K -30K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. Health

2.1 Basic Checks

  • ALQGC does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • ALQGC has about the same amout of shares outstanding than it did 1 year ago.
  • The debt/assets ratio for ALQGC is higher compared to a year ago.
ALQGC.PA Yearly Shares OutstandingALQGC.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M
ALQGC.PA Yearly Total Debt VS Total AssetsALQGC.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M

2.2 Solvency

  • Based on the Altman-Z score of -11.61, we must say that ALQGC is in the distress zone and has some risk of bankruptcy.
  • ALQGC's Altman-Z score of -11.61 is on the low side compared to the rest of the industry. ALQGC is outperformed by 84.29% of its industry peers.
  • ALQGC has a Debt/Equity ratio of 4.49. This is a high value indicating a heavy dependency on external financing.
  • With a Debt to Equity ratio value of 4.49, ALQGC is not doing good in the industry: 72.86% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 4.49
Debt/FCF N/A
Altman-Z -11.61
ROIC/WACCN/A
WACC7.48%
ALQGC.PA Yearly LT Debt VS Equity VS FCFALQGC.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M 20M

2.3 Liquidity

  • ALQGC has a Current Ratio of 2.73. This indicates that ALQGC is financially healthy and has no problem in meeting its short term obligations.
  • ALQGC's Current ratio of 2.73 is in line compared to the rest of the industry. ALQGC outperforms 60.00% of its industry peers.
  • ALQGC has a Quick Ratio of 2.73. This indicates that ALQGC is financially healthy and has no problem in meeting its short term obligations.
  • ALQGC has a Quick ratio (2.73) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.73
Quick Ratio 2.73
ALQGC.PA Yearly Current Assets VS Current LiabilitesALQGC.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 87.28% over the past year.
  • ALQGC shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -98.34%.
  • The Revenue for ALQGC have been decreasing by -79.70% on average. This is quite bad
EPS 1Y (TTM)87.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%92.58%
Revenue 1Y (TTM)-98.34%
Revenue growth 3Y-79.7%
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y6121.43%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year1744.53%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALQGC.PA Yearly Revenue VS EstimatesALQGC.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
ALQGC.PA Yearly EPS VS EstimatesALQGC.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1 2 3 4

More info and screens

Find the best growth stocksShow best growing peers

4

4. Valuation

4.1 Price/Earnings Ratio

  • ALQGC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • ALQGC is valuated cheaply with a Price/Forward Earnings ratio of 0.02.
  • ALQGC's Price/Forward Earnings ratio is rather cheap when compared to the industry. ALQGC is cheaper than 100.00% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of ALQGC to the average of the S&P500 Index (28.01), we can say ALQGC is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 0.02
ALQGC.PA Price Earnings VS Forward Price EarningsALQGC.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALQGC.PA Per share dataALQGC.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

  • ALQGC's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for ALQGC!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

QUANTUM GENOMICS SAS-REGR

EPA:ALQGC (10/24/2024, 7:00:00 PM)

0.0721

0 (-1.77%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)10-22
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap5.00M
Revenue(TTM)10.06K
Net Income(TTM)-3.17M
Analysts34.29
Price Target10.2 (14047.02%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 0.02
P/S 496.96
P/FCF N/A
P/OCF N/A
P/B 11.45
P/tB 11.45
EV/EBITDA N/A
EPS(TTM)-0.09
EYN/A
EPS(NY)4.34
Fwd EY6021.43%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0
BVpS0.01
TBVpS0.01
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -84.63%
ROE -726.18%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-87.78%
ROA(5y)-71.29%
ROE(3y)-517.57%
ROE(5y)-335.54%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 4.49
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.73
Quick Ratio 2.73
Altman-Z -11.61
F-ScoreN/A
WACC7.48%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)87.28%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%92.58%
EPS Next Y6121.43%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-98.34%
Revenue growth 3Y-79.7%
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year1744.53%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y89.57%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year3919.47%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

QUANTUM GENOMICS SAS-REGR / ALQGC.PA FAQ

What is the fundamental rating for ALQGC stock?

ChartMill assigns a fundamental rating of 1 / 10 to ALQGC.PA.


What is the valuation status of QUANTUM GENOMICS SAS-REGR (ALQGC.PA) stock?

ChartMill assigns a valuation rating of 4 / 10 to QUANTUM GENOMICS SAS-REGR (ALQGC.PA). This can be considered as Fairly Valued.


How profitable is QUANTUM GENOMICS SAS-REGR (ALQGC.PA) stock?

QUANTUM GENOMICS SAS-REGR (ALQGC.PA) has a profitability rating of 0 / 10.


Can you provide the financial health for ALQGC stock?

The financial health rating of QUANTUM GENOMICS SAS-REGR (ALQGC.PA) is 3 / 10.